Complimentary and alternative practices ranging from meditation to spinal manipulation show promise for contributing to pain management, according to a release by the American Pain Society.
Uncategorized
Recent studies have shown steep increases in abuse of powerful opioids like Vicodin, Hydrocodone and OxyContin, says Robert Saenz, CEO of Tulsa (Okla.) Pain Consultants and president of VIP Medical Consulting, which helps practices with compliance and business development. Authorities…
Jeff Hessing, MD, is an orthopedist and physician-owner of Treasure Valley Hospital in Boise, Idaho, as well as a member of the physician leadership team for Surgical Care Affiliates. He has been in practice for more than 25 years in…
Researchers found that a greater primary care workforce (with an FTE measure reflective of ambulatory primary care) could lead to more favorable patient outcomes among Medicare beneficiaries, according to a study published in the Journal of the American Medical Association.
In their study of risk factors for MRSA infection, researchers found patients’ age and antibiotic prophylaxis were not significantly associated with the adverse outcome, despite previous medical literature suggesting otherwise, according to a study published in the Journal of Orthopaedic…
bioMérieux, French manufacturer of diagnostic solutions, has received FDA 510(k) approval for NucliSENS EasyQ MRSA, an automated molecular test for MRSA, according to a company news release.
A Jackson Healthcare survey of 1,512 physicians found 82 percent did not receive compensation from prescriptions, lab tests, diagnostic imaging, hospital admissions or facility/surgery fees, according to a company news release.
A study presented at the recent American Pain Society meeting found that tapentadol ER can be used for analgesia in patients with hypertension because it does not significantly affect blood pressure or heart rate, according to a report by Clinical…
A U.S. Judicial Panel has consolidated lawsuits against DePuy on its Pinnacle metal-on-metal hip implant in a Texas federal court, according to a report by Mass Device.
Kensey Nash Corp. announced that it has acquired the assets including the product lines of Synthes' Norian subsidiary for $22 million in cash, according to a report by Reuters.
